Biotechnology Company
Appears in 1 story
Maker of GENGLYCOS; awaiting a second gene therapy decision
People with Glycogen Storage Disease Type Ia can't safely go without food. Their bodies can't release stored sugar, so many eat raw cornstarch around the clock, including overnight, to keep blood sugar from crashing. On August 19, 2026, the FDA approved GENGLYCOS, the first treatment aimed at the genetic cause of the disease rather than its symptoms.
Updated Yesterday
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
